The Use of Anticoagulants and Antiplatelet Agents among Outpatients in Alkharj

被引:0
|
作者
Ahmed, Nehad J. [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Alkharj, Saudi Arabia
关键词
Anticoagulant; antiplatelet; use; pattern; PREVENTION; THERAPY; STROKE; DRUGS;
D O I
10.9734/JPRI/2020/v32i1330580
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Thromboembolic diseases are a leading cause of mortality and morbidity worldwide. Anticoagulants and antiplatelet medications are important therapies in the prevention and treatment of cerebrovascular and cardiovascular diseases. There is a limited data about the prescribing of these medications. Aim: This study aims to describe the pattern of anticoagulants and antiplatelet agents use among outpatients in Alkharj. Methodology: This is a retrospective study that includes the electronic prescriptions among outpatients in a public hospital in Alkharj Results: Aspirin was the most commonly prescribed agent (61.73%) followed by clopidogrel (18.60%) and enoxaparin (69%). Aspirin and clopidogrel was the most commonly prescribed combination (77.27%). Antiplatelet agents and anticoagulants result in improve several benefits but also could result in severe adverse effects and several drug interactions. Conclusion: The prescribers should ensure that benefit of Antiplatelet and anticoagulant outweigh the bleeding risk before prescribing these medications. It is important also to implement educational interventions to improve their use.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [11] Treatment of blunt cerebrovascular injuries: Anticoagulants or antiplatelet agents?
    Hanna, Kamil
    Douglas, Molly
    Asmar, Samer
    Khurrum, Muhammad
    Bible, Letitia
    Castanon, Lourdes
    Ditillo, Michael
    Kulvatunyou, Narong
    Joseph, Bellal
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2020, 89 (01): : 74 - 79
  • [12] Use of Antiplatelet Agents far in the Neurosurgical Patient
    Zakeri, Amanda S.
    Nimjee, Shahid M.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2018, 29 (04) : 517 - +
  • [13] Current Status of Antiplatelet Agents to Prevent Stroke
    Field, Thalia S.
    Benavente, Oscar R.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 6 - 14
  • [14] New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents
    Rahman, Atifur
    Latona, Jilani
    AUSTRALIAN FAMILY PHYSICIAN, 2014, 43 (12) : 861 - 866
  • [15] Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy
    Satoshi Ono
    Mitsuhiro Fujishiro
    Kousuke Hirano
    Keiko Niimi
    Osamu Goto
    Shinya Kodashima
    Nobutake Yamamichi
    Kazuhiko Koike
    Journal of Gastroenterology, 2009, 44 : 1185 - 1189
  • [16] Antiplatelet agents and diabetes mellitus
    Drouet, L.
    Sollier, C. Bal Dit
    Henry, P.
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 : S104 - S112
  • [17] The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury
    Peck, Kimberly A.
    Calvo, Richard Y.
    Schechter, Mark S.
    Sise, C. Beth
    Kahl, Jessica E.
    Shackford, Meghan C.
    Shackford, Steven R.
    Sise, Michael J.
    Blaskiewicz, Donald J.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 76 (02): : 431 - 436
  • [18] Treatment of Extracranial Arterial Dissection: the Roles of Antiplatelet Agents, Anticoagulants, and Stenting
    Zakhar Serkin
    Scott Le
    Cathy Sila
    Current Treatment Options in Neurology, 2019, 21
  • [19] Treatment of Extracranial Arterial Dissection: the Roles of Antiplatelet Agents, Anticoagulants, and Stenting
    Serkin, Zakhar
    Le, Scott
    Sila, Cathy
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (10)
  • [20] The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage
    James, Robert F.
    Palys, Viktoras
    Lomboy, Jason R.
    Lamm, J. Richard, Jr.
    Simon, Scott D.
    NEUROSURGICAL FOCUS, 2013, 34 (05)